Thyroid storm is tumultuous and exciting; Myxedema is somewhat enervating and markedly less exciting–but it is also life threatening. We need to know about this disease! Today, I interview Arti Bhan, MD on the topic:
Arti Bhan, MD
Division Head, Endocrinology @HenryFord Health System
“I strive to provide the highest quality health care services to all my patients efficiently, effectively and compassionately. I believe in partnering with my patient in order to achieve our goals.”
Dr. Bhan received her medical degree from India. She completed an Internal Medicine Residency at St. John Hospital and Medical Center and then went on to a fellowship in Endocrinology at Henry Ford Health System.
She has been a senior staff physician at Henry Ford since 2003 and is currently serving as the Division Head of Endocrinology. She is active in clinical research and is an investigator in numerous trials, including NIH funded studies. She is published in peer reviewed literature and is the Associate Editor for Clinical Diabetes.
Dr. Bhan's main area of interest is in thyroid disorders, and she trains fellows in thyroid ultrasonography and thyroid biopsies.
What We Cover on Myxedema
- What is the look of myxedema
- What TSH should get you worried
- How to treat Myxedema
- Should we use T3 (LT3)
- What do resus docs screw up when treating myxedema
Related & More
- IBCC Myxedema
- EMCrit Thyroid Storm
- EMCrit 292 IV T3 for Myxedema Coma, A Different Take with Eve Bloomgarden
You Need an EMCrit Membership to see this content. Login here if you already have one.
- ODR 013 – Should, Must, & Won't - November 25, 2023
- EMCrit Shadowboxing Case 6 – A Respiratory Case along with Extra Commentary from Mae West - November 23, 2023
- EMCrit 362 – Jonathan Edlow, Lead Author of GRACE-3, on Dizziness - November 17, 2023